Ten-year visual outcome and change in chorioretinal atrophy after intravitreal ranibizumab for macular neovascularization in pathologic myopia.
Ryo SakataManabu MiyataSotaro OotoHiroshi TamuraNaoko Ueda-ArakawaYuki MuraokaMasahiro MiyakeMasayuki HataAyako TakahashiAi KidoShogo NumaYuki MoriKanae TsudaAkihito UjiAkio OishiAkitaka TsujikawaPublished in: Retina (Philadelphia, Pa.) (2023)
BCVA in eyes with mMNV in pathologic myopia was maintained for 10 years after a single IVR followed by a PRN regimen without drug-induced complications. The META-PM Study category progressed in 60% of eyes, especially those with older baseline age. Early diagnosis and treatment of mMNV are essential to maintain good long-term BCVA.
Keyphrases
- diabetic retinopathy
- optical coherence tomography
- drug induced
- liver injury
- optic nerve
- age related macular degeneration
- neoadjuvant chemotherapy
- vascular endothelial growth factor
- cataract surgery
- locally advanced
- air pollution
- squamous cell carcinoma
- particulate matter
- middle aged
- physical activity
- polycyclic aromatic hydrocarbons
- adverse drug
- radiation therapy